| Aaron Matthew Jordan, MD | |
|
200 Bunker Hill Dr, Aitkin, MN 56431-1865 | |
| (218) 927-2157 | |
| (218) 927-4130 |
| Full Name | Aaron Matthew Jordan |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 14 Years |
| Location | 200 Bunker Hill Dr, Aitkin, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184940090 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 54145 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Recover Health | Grand rapids, MN | Home health agency |
| Riverwood Healthcare Center | Aitkin, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aitkin Community Hospital Inc | 4981514692 | 61 |
News Archive
CardioGenics Holdings Inc., a developer of technology and products targeting the immunoassay segment of the IVD testing market, reports that Merck Chimie S.A.S. ("Merck Chimie") is progressing to the next phase of the commercialization of CardioGenics' proprietary silver coated paramagnetic Beads ("Beads").
Fear response to traumatic or threatening situations helps us evade or escape danger. At the same time fear response is learned in the form of association between stimulus or situation and the presence of a stressor.
A study published in the current issue of Cell Transplantation, now freely available on-line, reports that a team of researchers in South Korea have successfully engineered islet cell clusters (ICCs) that will improve pancreatic islet transplantation and offer promise for curing diabetes mellitus.
Seed investor CincyTech announced the formation of Kurome Therapeutics ("Kurome"), a preclinical stage company developing novel therapies targeting cancer cells' adaptive resistance mechanisms beginning with hematopoietic, or blood cell, cancers.
› Verified 7 days ago
| Entity Name | Aitkin Community Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942277835 PECOS PAC ID: 4981514692 Enrollment ID: O20031107000093 |
News Archive
CardioGenics Holdings Inc., a developer of technology and products targeting the immunoassay segment of the IVD testing market, reports that Merck Chimie S.A.S. ("Merck Chimie") is progressing to the next phase of the commercialization of CardioGenics' proprietary silver coated paramagnetic Beads ("Beads").
Fear response to traumatic or threatening situations helps us evade or escape danger. At the same time fear response is learned in the form of association between stimulus or situation and the presence of a stressor.
A study published in the current issue of Cell Transplantation, now freely available on-line, reports that a team of researchers in South Korea have successfully engineered islet cell clusters (ICCs) that will improve pancreatic islet transplantation and offer promise for curing diabetes mellitus.
Seed investor CincyTech announced the formation of Kurome Therapeutics ("Kurome"), a preclinical stage company developing novel therapies targeting cancer cells' adaptive resistance mechanisms beginning with hematopoietic, or blood cell, cancers.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aaron Matthew Jordan, MD 200 Bunker Hill Dr, Aitkin, MN 56431-1865 Ph: (218) 927-2157 | Aaron Matthew Jordan, MD 200 Bunker Hill Dr, Aitkin, MN 56431-1865 Ph: (218) 927-2157 |
News Archive
CardioGenics Holdings Inc., a developer of technology and products targeting the immunoassay segment of the IVD testing market, reports that Merck Chimie S.A.S. ("Merck Chimie") is progressing to the next phase of the commercialization of CardioGenics' proprietary silver coated paramagnetic Beads ("Beads").
Fear response to traumatic or threatening situations helps us evade or escape danger. At the same time fear response is learned in the form of association between stimulus or situation and the presence of a stressor.
A study published in the current issue of Cell Transplantation, now freely available on-line, reports that a team of researchers in South Korea have successfully engineered islet cell clusters (ICCs) that will improve pancreatic islet transplantation and offer promise for curing diabetes mellitus.
Seed investor CincyTech announced the formation of Kurome Therapeutics ("Kurome"), a preclinical stage company developing novel therapies targeting cancer cells' adaptive resistance mechanisms beginning with hematopoietic, or blood cell, cancers.
› Verified 7 days ago
Erik Bostrom, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Bunker Hill Dr, Aitkin, MN 56431 Phone: 218-927-2157 | |
Mr. Timothy J Arnold, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Bunker Hill Dr, Aitkin, MN 56431 Phone: 218-927-2157 Fax: 218-927-4130 | |
David Douglas Taylor, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Bunker Hill Dr, Aitkin, MN 56431 Phone: 218-927-2121 | |
Mark E. Heggem, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 Bunker Hill Dr, Aitkin, MN 56431 Phone: 218-927-2157 Fax: 218-927-4130 | |
Donald B Hughes, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Bunker Hill Dr, Aitkin, MN 56431 Phone: 218-927-2157 Fax: 218-927-4130 | |
Charles P Schotzko, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 Bunker Hill Dr, Aitkin, MN 56431 Phone: 218-927-2157 Fax: 218-927-4130 |